BRPI0810323A2 - "combinação de ácido pirrolidona 5-carboxílico, uso do ácido pirrolidona 5-carboxílico, composição e seu uso" - Google Patents

"combinação de ácido pirrolidona 5-carboxílico, uso do ácido pirrolidona 5-carboxílico, composição e seu uso"

Info

Publication number
BRPI0810323A2
BRPI0810323A2 BRPI0810323-2A2A BRPI0810323A BRPI0810323A2 BR PI0810323 A2 BRPI0810323 A2 BR PI0810323A2 BR PI0810323 A BRPI0810323 A BR PI0810323A BR PI0810323 A2 BRPI0810323 A2 BR PI0810323A2
Authority
BR
Brazil
Prior art keywords
pyrolidone
carboxylic
acid
composition
combination
Prior art date
Application number
BRPI0810323-2A2A
Other languages
English (en)
Inventor
Johannes Voegel
Emmanuelle At
Carine Rosignoli
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of BRPI0810323A2 publication Critical patent/BRPI0810323A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
BRPI0810323-2A2A 2007-05-22 2008-05-22 "combinação de ácido pirrolidona 5-carboxílico, uso do ácido pirrolidona 5-carboxílico, composição e seu uso" BRPI0810323A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0755186A FR2916351B1 (fr) 2007-05-22 2007-05-22 Composition pharmaceutique comprenant au moins deux composes choisis parmi l'acide pyrrolidone-5-carboxylique, la citrulline, l'arginine et l'asparagine et leur utilisation dans le traitement de la dermatite atopique
US92471207P 2007-05-29 2007-05-29
PCT/EP2008/056333 WO2008142147A1 (en) 2007-05-22 2008-05-22 Combination comprising pyrrolidone-5-carboxylic acid and at least one compound from citrulline, arginine and asparagine, and use thereof in the treatment of atopic dermatitis

Publications (1)

Publication Number Publication Date
BRPI0810323A2 true BRPI0810323A2 (pt) 2014-10-14

Family

ID=38606551

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810323-2A2A BRPI0810323A2 (pt) 2007-05-22 2008-05-22 "combinação de ácido pirrolidona 5-carboxílico, uso do ácido pirrolidona 5-carboxílico, composição e seu uso"

Country Status (15)

Country Link
US (1) US8795705B2 (pt)
EP (2) EP2218452B1 (pt)
JP (2) JP2010527970A (pt)
KR (1) KR20100017202A (pt)
CN (1) CN101686957A (pt)
BR (1) BRPI0810323A2 (pt)
CA (1) CA2687324A1 (pt)
ES (2) ES2554834T3 (pt)
FR (1) FR2916351B1 (pt)
HU (2) HUE025824T2 (pt)
MX (1) MX2009012472A (pt)
PL (2) PL2164482T3 (pt)
PT (2) PT2164482E (pt)
RU (1) RU2476214C2 (pt)
WO (1) WO2008142147A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5689026B2 (ja) * 2010-06-17 2015-03-25 株式会社 資生堂 水中油型乳化皮膚化粧料
KR101066859B1 (ko) * 2010-12-10 2011-09-26 전명자 패드 및 이를 포함하는 깔창
JP6009147B2 (ja) * 2011-03-15 2016-10-19 株式会社 資生堂 ブレオマイシン水解酵素産生促進剤
RU2538084C1 (ru) * 2013-07-25 2015-01-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Уральская государственная медицинская академия Министерства здравоохранения и социального развития Российской Федерации" (ГБОУ ВПО УГМА Минздрава России) Средство для лечения и профилактики атопического дерматита
KR101732428B1 (ko) 2015-06-25 2017-05-24 이정재 탄성 리포좀 조성물 및 이를 포함하는 화장료 조성물
KR102396603B1 (ko) 2015-09-16 2022-05-11 원광대학교산학협력단 시트룰린을 유효성분으로 함유하는 간 기능 개선용 조성물
US9909427B2 (en) 2015-12-22 2018-03-06 General Electric Company Turbine airfoil with trailing edge cooling circuit
EP4397368A3 (en) * 2016-06-17 2024-10-16 Drug Delivery Solutions APS Formulation for use in the treatment of uremic pruritus
CN112137995A (zh) 2019-06-28 2020-12-29 默克专利股份有限公司 增加皮肤细胞中钙的细胞利用率的方法和混合物
CN112569162B (zh) * 2019-09-27 2024-04-12 默克专利股份有限公司 麦冬提取物、氨基酸、氨基酸衍生物和乳酸钙水合物的协同作用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61215308A (ja) 1985-03-20 1986-09-25 Shiseido Co Ltd 皮膚外用剤
JPS61215307A (ja) 1985-03-20 1986-09-25 Shiseido Co Ltd 皮膚外用剤
JPH0729911B2 (ja) 1986-05-15 1995-04-05 株式会社資生堂 皮膚外用剤
US4837019A (en) * 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
DE4341000A1 (de) * 1993-12-02 1995-06-08 Beiersdorf Ag Verwendung von L-Arginin, L-Ornithin oder L-Citrullin und topischen Zubereitungen mit diesen Stoffen
JPH0820525A (ja) 1994-07-06 1996-01-23 Nendo Kagaku Kenkyusho:Kk ボディシャンプ
MX9710479A (es) 1995-09-07 1998-03-31 Oreal Extracto de iridaceas y composiciones que la contienen.
JP3949720B2 (ja) 1995-09-07 2007-07-25 ロレアル 非光合成糸状細菌からの抽出物の使用とそれを含む組成物
JP3525233B2 (ja) * 1995-09-20 2004-05-10 味の素株式会社 化粧料
FR2768622B1 (fr) 1997-09-22 1999-11-26 Oreal Extrait de rosacees en tant qu'antagoniste de bradykinine
FR2778562B1 (fr) * 1998-05-14 2000-08-04 Sephra Composition pharmaceutique, hygienique et/ou cosmetique contenant de l'eau de mer et de l'arginine
DE19831798A1 (de) * 1998-07-15 2000-01-27 Mandorlo Investment Gmbh Luxem Mittel zur Pflege und/oder Behandlung von Haut und Gewebe
JP2002053428A (ja) 2000-08-12 2002-02-19 Tadashi Fukiya 皮膚外用剤
JP4681132B2 (ja) * 2001-01-29 2011-05-11 味の素株式会社 一酸化窒素合成酵素産生促進剤および化粧料若しくは医薬組成物
DE10111049A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen, zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter trockener Haut
JP4851046B2 (ja) * 2002-06-19 2012-01-11 味の素株式会社 細胞への塩基性アミノ酸取り込み促進剤および医薬組成物
JP2004168763A (ja) * 2002-10-30 2004-06-17 Dsr Corp 皮膚化粧料
US20060063827A1 (en) * 2004-09-23 2006-03-23 Yu Ruey J Systemic administration of therapeutic amino acids and N-acetylamino acids
TW200533333A (en) 2004-02-17 2005-10-16 Otsuka Pharma Co Ltd Human beta-defensin production accelerator

Also Published As

Publication number Publication date
EP2218452A1 (en) 2010-08-18
US20100291002A1 (en) 2010-11-18
EP2164482A1 (en) 2010-03-24
CN101686957A (zh) 2010-03-31
ES2554776T3 (es) 2015-12-23
HUE026388T2 (en) 2016-06-28
PT2218452E (pt) 2016-01-27
EP2218452B1 (en) 2015-09-30
JP2014065742A (ja) 2014-04-17
PL2164482T3 (pl) 2016-05-31
KR20100017202A (ko) 2010-02-16
WO2008142147A1 (en) 2008-11-27
FR2916351B1 (fr) 2012-12-07
PT2164482E (pt) 2016-02-03
HUE025824T2 (en) 2016-05-30
JP2010527970A (ja) 2010-08-19
US8795705B2 (en) 2014-08-05
FR2916351A1 (fr) 2008-11-28
ES2554834T3 (es) 2015-12-23
PL2218452T3 (pl) 2016-04-29
RU2476214C2 (ru) 2013-02-27
EP2164482B1 (en) 2015-10-07
RU2009147465A (ru) 2011-06-27
AU2008252925A1 (en) 2008-11-27
CA2687324A1 (en) 2008-11-27
MX2009012472A (es) 2009-12-01

Similar Documents

Publication Publication Date Title
BRPI0810323A2 (pt) "combinação de ácido pirrolidona 5-carboxílico, uso do ácido pirrolidona 5-carboxílico, composição e seu uso"
BRPI0911688A2 (pt) "compostos de pirimidina, composições e métodos de uso"
SMT201400181B (it) Composizioni per vasocostrizione e metodi d'uso
SMT201500206B (it) Composti spiro-ossindolici e loro uso come agenti terapeutici
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
BRPI0912928A2 (pt) "composto, e, composição isenta de pirogênio"
BRPI0913806A2 (pt) "composição"
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0912717A2 (pt) Composição farmacêutica, e, uso de 5-azacitidina
BRPI0909954A2 (pt) "diazacarbazóis e métodos de uso"
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
BRPI0618904A2 (pt) composto, composição farmacêutica, e, uso do composto
BRPI0813341A2 (pt) " uso de compostos, composições curáveis, e, uso de composições curáveis ".
BRPI0717699A2 (pt) "composição e seus processos de preparação, uso de uma composição e uso coméstico de uma composição!
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
BRPI0720124A2 (pt) Composições farmacêuticas e seus métodos de uso.
BRPI0716327A2 (pt) Composto de fenilpropionamida e uso
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0719497A2 (pt) "composição, processo de preparação de uma composição, usos de uma composição e uso coméstico de uma composição"
BRPI0911938A2 (pt) composição, líquido de diálise, uso do líquido de diálise, e, preparação combinada
AU2006255829A8 (en) Improvements in or relating to pasture management
BRPI0907365A2 (pt) Composição antimicrobiana e uso
BRPI0819047A2 (pt) "composição, seu processo de preparação e seus usos"
BRPI1006974A2 (pt) "uso de absorvedores de uv, e, composição cosmética."
BRPI0808172A2 (pt) Compostos heterocíclicos, composições compreendendo-os e métodos de seu uso.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]